Musaffa Logo
Valneva SE VLA.VI

Last Updated: Jul 17, 12:00 AM·WBAG

VLA.VI Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Valneva SE is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Valneva SE

Valneva SE. Stock Analysis VLA.VI

Austria Health Care Small Cap Report:
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 694 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!